Back

Comparative effectiveness and safety of non-VKA oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with differential treatment duration: an ARISTOPHANES study analysis

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation and oral anticoagulation 6 Oral Anticoagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Ms Amiee Kang

Bristol Myers Squibb, Princeton (United States of America)

9 More presentations in this session

Presentation thumbnail
Mr J. Choi (Busan, KR)
Abstract Slides
Presentation thumbnail
Doctor J. Strange (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Doctor T. Chao (Taipei, TW)
Abstract
Presentation thumbnail
Professor H. Bonnemeier (Luebeck, DE)
Abstract Slides
Presentation thumbnail
Doctor C. Boerschel (Hamburg, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation and oral anticoagulation 6

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Real-world insights on anticoagulation therapies in non-valvular atrial fibrillation: a comprehensive electronic health record-based study using natural language processing and machine learning
thumbnail
Congress Presentation
Comparative efficacy and safety of antithrombotic regimens following left atrial appendage occlusion therapy in atrial fibrillation patients: a comprehensive Bayesian network meta-analysis
thumbnail
Congress Presentation
Safety and efficacy of anticoagulation therapy post atrial fibrillation ablation

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources